RYTM - Rhythm Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.79
|
Rev Est: $56.2M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$143.13
DETAILS
HIGH:
$157.00
LOW:
$125.00
MEDIAN:
$143.50
CONSENSUS:
$143.13
UPSIDE:
45.09%
Market Cap:
6.58B
Volume:
775,705
Avg Volume:
759,066
52 Week Range:
45.905-122.2
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.04
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
283
IPO Date:
2017-10-09
EPS (TTM):
-4.34
P/E Ratio:
-13.10
Revenue (TTM):
130.13M
Total Assets:
392.27M
Total Debt:
3.94M
Cash & Equiv:
89.14M
Rev Growth (5Y):
245.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-86.6%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.82 | $-0.72 | -13.9% | $51.3M | $56.0M | -8.4% |
| 2025-08-05 | $-0.75 | $-0.66 | -13.6% | $48.5M | $51.3M | -5.5% |
| 2025-05-07 | $-0.81 | $-0.69 | -17.4% | $32.7M | $43.3M | -24.4% |
| 2025-02-26 | $-0.72 | $-0.69 | -4.3% | $41.8M | $38.5M | +8.7% |
| 2024-11-05 | $-0.73 | $-0.80 | +8.8% | $33.3M | $35.9M | -7.4% |
| 2024-08-06 | $-0.55 | $-0.70 | +21.4% | $29.1M | $28.8M | +1.0% |
| 2024-05-07 | $-2.35 | $-2.34 | -0.4% | $26.0M | $28.8M | -9.8% |
| 2024-02-22 | $-0.70 | $-0.70 | 0.0% | $24.2M | $25.4M | -4.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 130.13M | 77.43M | 23.64M | 3.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (260.60M) | (184.68M) | (181.12M) | (69.61M) | (130.73M) | (134.62M) | (74.06M) | (33.71M) | (25.87M) | (11.07M) | (6.49M) | (21.43M) |
| EPS | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 | -1.26 | -1.55 | -1.09 | -0.64 | -0.43 |
| Total Assets | 392.27M | 332.75M | 382.48M | 329.52M | 187.07M | 308.52M | 260.21M | 151.74M | 12.34M | 37.27M | 194,000 | 18.19M |
| Total Debt | 3.94M | 1.26M | 1.94M | 2.55M | 3.09M | 3.56M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 89.14M | 60.08M | 127.68M | 59.25M | 100.85M | 62.29M | 49.54M | 34.24M | 6.54M | 34.87M | 152,000 | 7.36M |
| Operating Cash Flow | (113.88M) | (136.16M) | (173.43M) | (146.00M) | (121.98M) | (122.75M) | (62.06M) | (29.46M) | (23.22M) | (6.98M) | (7.51M) | (19.16M) |
| Free Cash Flow | (113.88M) | (136.20M) | (177.71M) | (151.44M) | (122.19M) | (126.14M) | (62.78M) | (29.59M) | (24.28M) | (6.99M) | (7.51M) | (19.16M) |
| FCF per Share | -1.87 | -2.36 | -3.41 | -3.05 | -2.77 | -3.46 | -2.02 | -1.11 | -1.45 | -0.69 | -0.74 | -0.38 |
| Book Value | 164.55M | 169.76M | 264.26M | 284.15M | 166.53M | 281.02M | 246.26M | 144.79M | 7.30M | 32.00M | (358,000) | (57.46M) |
| Cash & ST Investments | 320.56M | 275.85M | 333.29M | 294.86M | 172.79M | 292.46M | 252.06M | 148.08M | 10.54M | 34.87M | 152,000 | 17.76M |
| ROC Equity | -1.58 | -1.09 | -0.69 | -0.24 | -0.79 | -0.48 | -0.30 | -0.23 | -3.55 | -0.35 | N/A | N/A |